RTI-7470-44(Cat No.:I043383)is a selective small molecule inhibitor designed to target the protein kinase CK1δ (casein kinase 1 delta), an enzyme involved in regulating various cellular processes such as circadian rhythms, cell cycle progression, and cellular signaling. CK1δ is implicated in a variety of diseases, including cancer and neurodegenerative disorders. By inhibiting CK1δ, RTI-7470-44 aims to modulate these processes, offering potential therapeutic applications in cancer and neurological diseases. This compound is being studied for its ability to selectively disrupt CK1δ activity, providing a targeted approach to treating diseases linked to this kinase.